iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
iRhythm Technologies (NASDAQ: IRTC) will participate in the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iRhythm Technologies (NASDAQ: IRTC) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 4:30 p.m. ET/1:30 p.m. PT. This leading digital healthcare company focuses on innovative solutions for disease detection, prediction, and prevention. The management presentation will be available via live and archived webcast on the company's Investors website. iRhythm combines wearable biosensors with advanced data analytics to deliver actionable health insights, aiming to improve patient outcomes.
Details
News Market Reaction – IRTC
The recorded move for IRTC in the trading session of this news was +1.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
iRhythm’s management is scheduled to present on Tuesday, January 10, 2023, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Relations Contact:
Stephanie Zhadkevich
(919) 452-5430
stephanie.zhadkevich@irhythmtech.com
iRhythm Media Contact:
Morgan Mathis
(310) 528-6306
irhythm@highwirepr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.